Celldex Therapeutics Inc (CLDX)
EBITDA Growth
-30.28%
Quarterly · Period ending:
CLDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.28%period ending
Latest reported-30.28%period ending
CLDX Quarterly EBITDA YoY % (500.00% → -30.28%)
Year-over-year change
High-resolution chart · PNG
CLDX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -107.7641% | |
| -60.8696% | |
| -32.1771% | |
| -91.8143% | |
| -37.7645% | |
| -7.525% | |
| -92.4053% | |
| 0% | |
| -30.14% | |
| -71.4286% | |
| -18.75% | |
| -5% | |
| 16.6667% | |
| 26.3158% | |
| 38.4615% | |
| 4.7619% | |
| 58.1395% | |
| 9.5238% | |
| 10.3448% | |
| 34.375% | |
| -72% | |
| 16% | |
| -45% | |
| -39.1304% | |
| -4.1667% | |
| -19.0476% | |
| 4.7619% | |
| 14.8148% | |
| -41.1765% | |
| -5% | |
| -145.4545% | |
| -21.4286% | |
| -17.6471% | |
| 42.1053% | |
| 12.5% | |
| -54.5455% | |
| 22.2222% | |
| -137.5% | |
| -45.4545% | |
| -650% | |
| -800% | |
| -133.3333% | |
| -152.381% | |
| 102.8169% | |
| -105.2632% | |
| 26.3158% | |
| 23.5294% | |
| -22.4138% | |
| 26.6667% | |
| 58.3333% | |
| 70% | |
| -61.1111% | |
| 87.5% | |
| 100% | |
| 400% | |
| -80% | |
| 700% | |
| 500% |